Do Cryopreserved Mesenchymal Stromal Cells Display Impaired Immunomodulatory and Therapeutic Properties?
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Do Cryopreserved Mesenchymal Stromal Cells Display Impaired Immunomodulatory and Therapeutic Properties?
Authors
Keywords
-
Journal
STEM CELLS
Volume 32, Issue 9, Pages 2430-2442
Publisher
Wiley
Online
2014-05-08
DOI
10.1002/stem.1729
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mesenchymal stem cells: immune evasive, not immune privileged
- (2014) James A Ankrum et al. NATURE BIOTECHNOLOGY
- Do ABO Blood Group Antigens Hamper the Therapeutic Efficacy of Mesenchymal Stromal Cells?
- (2014) Guido Moll et al. PLoS One
- Tissue factor triggers procoagulation in transplanted mesenchymal stem cells leading to thromboembolism
- (2013) Kohei Tatsumi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Autologous and allogeneic mesenchymal stem cells in organ transplantation
- (2013) Senthilkumar Alagesan et al. Current Opinion in Organ Transplantation
- Duration of in vitro storage affects the key stem cell features of human bone marrow-derived mesenchymal stromal cells for clinical transplantation
- (2013) Hoon Sang Sohn et al. CYTOTHERAPY
- The mesenchymal stromal cells dilemma—does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?
- (2013) Jacques Galipeau CYTOTHERAPY
- Regulation of stem cell therapies under attack in Europe: for whom the bell tolls
- (2013) Paolo Bianco et al. EMBO JOURNAL
- Study of the stability of packaging and storage conditions of human mesenchymal stem cell for intra-arterial clinical application in patient with critical limb ischemia
- (2013) Patricia Gálvez-Martín et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine
- (2013) Paolo Bianco et al. NATURE MEDICINE
- Mesenchymal Stem Cells Engineered to Inhibit Complement-Mediated Damage
- (2013) Melisa A. Soland et al. PLoS One
- Safety and efficacy of intravenous infusion of allogeneic cryopreserved mesenchymal stem cells for treatment of chronic kidney disease in cats: results of three sequential pilot studies
- (2013) Jessica M Quimby et al. Stem Cell Research & Therapy
- Mesenchymal stem cells are injured by complement after their contact with serum
- (2012) Y. Li et al. BLOOD
- Bivalirudin in Combination with Heparin to Control Mesenchymal Cell Procoagulant Activity
- (2012) Xavier Stephenne et al. PLoS One
- Are Therapeutic Human Mesenchymal Stromal Cells Compatible with Human Blood?
- (2012) Guido Moll et al. STEM CELLS
- Analysis of Tissues Following Mesenchymal Stromal Cell Therapy in Humans Indicates Limited Long-Term Engraftment and No Ectopic Tissue Formation
- (2012) L. von Bahr et al. STEM CELLS
- Mesenchymal Stem Cells: Mechanisms of Inflammation
- (2011) Nora G. Singer et al. Annual Review of Pathology-Mechanisms of Disease
- Long-Term Complications, Immunologic Effects, and Role of Passage for Outcome in Mesenchymal Stromal Cell Therapy
- (2011) Lena von Bahr et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Tissue-Engineered Airway: A Regenerative Solution
- (2011) P Jungebluth et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing
- (2011) Moïra François et al. CYTOTHERAPY
- Mesenchymal Stromal Cells Engage Complement and Complement Receptor Bearing Innate Effector Cells to Modulate Immune Responses
- (2011) Guido Moll et al. PLoS One
- Oral Mucosal Progenitor Cells Are Potently Immunosuppressive in a Dose-Independent Manner
- (2011) Lindsay C. Davies et al. STEM CELLS AND DEVELOPMENT
- Therapeutic Applications of Mesenchymal Stromal Cells: Paracrine Effects and Potential Improvements
- (2011) Joyce Doorn et al. TISSUE ENGINEERING PART B-REVIEWS
- Evaluation of Bone Marrow-Derived Mesenchymal Stem Cells After Cryopreservation and Hypothermic Storage in Clinically Safe Medium
- (2011) Irene Ginis et al. TISSUE ENGINEERING PART C-METHODS
- Intravenous apoptotic cell infusion as a cell-based therapy toward improving hematopoietic cell transplantation outcome
- (2010) Philippe Saas et al. Annals of the New York Academy of Sciences
- What do we mean when we write “senescence,”“apoptosis,”“necrosis,” or “clearance of dying cells”?
- (2010) Dror Mevorach et al. Annals of the New York Academy of Sciences
- Complement: a key system for immune surveillance and homeostasis
- (2010) Daniel Ricklin et al. NATURE IMMUNOLOGY
- Mesenchymal stem cell therapy: Two steps forward, one step back
- (2010) James Ankrum et al. TRENDS IN MOLECULAR MEDICINE
- Properdin: Emerging Roles of a Pattern-Recognition Molecule
- (2009) Claudia Kemper et al. Annual Review of Immunology
- Optimizing in vitro conditions for immunomodulation and expansion of mesenchymal stromal cells
- (2009) H. Samuelsson et al. CYTOTHERAPY
- Can cells and biomaterials in therapeutic medicine be shielded from innate immune recognition?
- (2009) Bo Nilsson et al. TRENDS IN IMMUNOLOGY
- Effect of holding time, temperature and different parenteral solutions on viability and functionality of adult bone marrow-derived mesenchymal stem cells before transplantation
- (2008) Rakhi Pal et al. Journal of Tissue Engineering and Regenerative Medicine
- Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
- (2008) Katarina Le Blanc et al. LANCET
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now